Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
21 June 2024 | Story Precious Shamase | Photo Suplied
Prof Jesse Lutabingwa
Prof Jesse Lutabingwa, the visiting scholar who will be facilitating grant-writing workshops to support third-stream aspirations.

The University of the Free State (UFS) welcomes Prof Jesse Lutabingwa, a visiting Fellow from the Appalachian State University (AppState) in the United States. Prof Lutabingwa arrives under the prestigious Carnegie African Diaspora Fellowship Programme (CADFP), bringing a wealth of experience to support the university's ‘third-income aspirations.’

Prof Lutabingwa’s long-standing connection with the UFS began in 2009 when he played a pivotal role in establishing a collaborative partnership between the two institutions. At the time, he was serving as Associate Vice-Chancellor for International Education and Development at AppState. Now, he returns not as an administrator, but as a faculty member eager to share his expertise and deepen this valuable connection.

"I have always wanted to participate in CADFP to give back to the African continent," Prof Lutabingwa explains. "This fellowship allows me to engage with the UFS community on different issues and contribute to the professional and individual growth of faculty, staff, and students, ultimately serving our communities better."

Empowering through grant writing

A key aspect of Prof Lutabingwa’s fellowship is a series of grant-writing workshops designed to empower UFS faculty, researchers, and postgraduate students, particularly on the Qwaqwa Campus.

"Many find the idea of proposing research grants daunting," Prof Lutabingwa says. "My goal is to elucidate the process. With more than 33 years of experience and more than 65% success rate, I am here to share the knowledge I have gained as a grant writer and reviewer."

These workshops will equip participants with the skills and strategies needed to craft compelling proposals, significantly increasing their chances of securing funding. Access to grants is crucial, Prof Lutabingwa emphasises, as it allows researchers to pursue innovative work that benefits society while offering valuable training opportunities for students.

Collaboration for research impact

Prof Lutabingwa’s contributions extend beyond workshops. He will collaborate with Dr Grey Magaiza, Director of the Centre for Gender and Africa Studies, and other faculty members on co-authoring two research articles. This collaboration aims to strengthen the UFS' research profile and contribute to a more impactful research landscape.

Dr Magaiza highlights the significance of Prof Lutabingwa’s visit: "Jesse is at the heart of the UFS-AppState partnership. Now, as a Carnegie Africa Diaspora fellow, he can engage with us in a new way, pouring his expertise back into this space. His grant-writing workshops and collaborative research efforts will be instrumental in achieving our third-stream aspirations."

Excited about the future

The fellow’s enthusiasm for this fellowship is noticeable when he speaks and engages with colleagues on campus. "Words cannot express my excitement," he shares. "I am grateful for this opportunity to collaborate, engage in research, and connect with various individuals on campus."

The UFS community warmly welcomes Prof Lutabingwa and anticipates a fruitful fellowship that will empower faculty, strengthen research, and propel the UFS – particularly the Qwaqwa Campus – towards achieving its third-income aspirations.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept